Historical record - last NADAC publication: 3/20/2019
Product Information
TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $3.6356 per EA under NDC 68462032901. Its NADAC has been published 167 times since May 18, 2016.
Strength
4; 240 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032901
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
3/20/2019
Active Ingredients
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079135On Market Since
2/25/2015
Pharmacological Classes
Price Statistics
The NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has been published 167 times since May 18, 2016, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6356 per EA |
|---|---|
| All-time high | $4.0543 (Sep 13, 2017) |
| All-time low | $3.6356 (Aug 22, 2018) |
| Median price | $3.8248 |
| Average price | $3.8205 |
| Largest weekly change | -8.9% (Aug 22, 2018) |
| Weeks tracked | 167 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Trandolapril and Verapamil Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $3.6356 per EA (NDC 68462032901), effective Aug 14, 2019.
How has the price of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has declined 5.4%. It has been tracked across 167 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?
Since May 18, 2016, the NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has ranged from a low of $3.6356 (Aug 22, 2018) to a high of $4.0543 (Sep 13, 2017), with a median of $3.8248 per EA.
Are there cheaper alternatives to TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?
TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET (NDC 68462032901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification